Foresee Pharmaceuticals Co LtdForesee Pharmaceuticals Co Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Full ESG assessment of Foresee Pharmaceuticals Co Ltd are reached by signing up for free. Other companies in the scoring peer group for Foresee Pharmaceuticals Co Ltd are shown below. This page includes a Q&A table for Foresee Pharmaceuticals Co Ltd.

Foresee Pharmaceuticals Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.5; made up of an environmental score of 1.6, social score of 0.0 and governance score of 0.0.

SDG Transparency Score for Foresee Pharmaceuticals Co Ltd 

0.5

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Foresee Pharmaceuticals Co Ltd 
1.6

Environmental

0.0

Social

0.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
.........
2628Orient Europharma Co Ltd
0.7
Low
2628Shandong Jintai Group Co Ltd
0.7
Low
2634Foresee Pharmaceuticals Co Ltd
0.5
Low
2634American Green Inc
0.5
Low
2634Arrayit Corp
0.5
Low
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Foresee Pharmaceuticals Co Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd offer flexible work?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose water use targets?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Foresee Pharmaceuticals Co Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Foresee Pharmaceuticals Co Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Foresee Pharmaceuticals Co Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Foresee Pharmaceuticals Co Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Foresee Pharmaceuticals Co Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Foresee Pharmaceuticals Co Ltd
These potential risks are based on the size, segment and geographies of the company.

Foresee Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, engages in the development and commercialization of drugs in the United States, China, and Europe. The company's stabilized injectable formulation pipeline includes FP-001, which completed Phase III clinical study for the treatment of advanced stage prostate cancer; FP-004 that is in preclinical stage to treat opioids use disorder; FP-011 and FP-014, a long-acting sustained release dosage form for the treatment of breast cancer/prostate cancer; and FP-016 for the treatment of neurological diseases. Its new chemical entity pipeline products consist of FP-020 to treat sarcoidosis, idiopathic pulmonary fibrosis, and pulmonary emphysema; FP-025, a selective matrix metalloproteinase-12 inhibitor, which is in Phase II clinical trial for the treatment of asthma, chronic obstructive pulmonary diseases, and acute respiratory distress syndrome in COVID-19 patients; and FP-045, a selective aldehyde dehydrogenase (ALDH2) activator that completed Phase I clinical study for the treatment of fanconi anemia, as well as FP-040, an ALDH2 activator to treat central nervous system diseases. The company was incorporated in 2013 and is based in Taipei, Taiwan.

Sorry!

Failed to process!